+39 331 386 7522 info@isheo.com

News & Insights

ATMPs & Patient Awareness

Webinar ATMPs & Patient AwarenessLearn about patient's awareness for ATMPs and challenges in evidence generation. Our experts discuss the most recent evidence on patient's and public perspectives, barriers to engagement and evaluation of patients' experience....

ATMP Think Tank

Driven by unmet medical needs, the ATMP Think Tank will promote innovative therapeutics in European countries. The ATMP Think Tank means to be simultaneously inclusive and a well-balanced reflection of stakeholders from the development chain. From academics to bedside. Contact us to contribute!

Isheo Bulletin – Epidermolysis Bullosa

Isheo Research Bulletin 1.2021 on Rare DiseaseThe unmet need of patients withEpidermolysis BullosaGet the RIGHT ACCESSThe access of patients with rare diseases matters, it is not just a slogan but a way to remember that patients with rare diseases often find it...

Evidence Synthesis in the EU

In this webinar, ISHEO and AREX Advisor focused on presenting an overview of how different EU countries apply Evidence Synthesis to provide a compass and help professionals navigate the sea of ​​uncertainty created by the vast set of studies present today. Together,...

What are Patient Reported Outcomes

During the last webinar, 'Patient-Reported Outcomes' organized by ISHEO into its Access matters webinar series, Davide Integlia, CEO of ISHEO, interviews Linda Abet Webb, CEO of P-COA, focusing on how Patient-Reported Outcomes are becoming increasingly crucial for...

Market Access in Italy

What does "Access" mean? Nowadays, the concept of "access" is comprehensive and needs to be declined in its multiple meanings. In particular, we can consider three different definitions of "access". Access to treatment means the provision of hospitals, institutions,...